Source:http://linkedlifedata.com/resource/pubmed/id/12472511
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
6
|
pubmed:dateCreated |
2002-12-10
|
pubmed:abstractText |
11Beta-hydroxysteroid dehydrogenase 1 (11beta-HSD1) has been identified as a major detoxification enzyme of one of the most potent tobacco smoke-derived carcinogens, NNK. If not metabolized by 11beta-HSD1, activation of NNK by cytochrome p450 mono-oxidase 2D6 (CYP2D6) results in an electrophile intermediate responsible for DNA damage. Interindividual variability in the expression of 11beta-HSD1 and CYP2D6 has been found to influence the susceptibility to lung cancer. The aim of this study was to compare 11beta-HSD1 mRNA expression and CYP2D6 metabolizer status in pharyngeal tissues of patients with oropharyngeal carcinoma and controls. In 20 patients with oropharyngeal cancer and 15 non-smoking controls, the 11beta-HSD1 mRNA expression was assessed with RT-PCR. The frequency of genetic polymorphisms of the CYP2D6 gene was assessed using RFLP. It was found that 11beta-HSD1 mRNA is expressed in human pharyngeal mucosa. It is upregulated in mucosa exposed to tobacco smoke. In tumour tissues, 11beta-HSD1 expression was significantly lower than in non-affected mucosa. The frequency distribution of CYP2D6 gene polymorphisms was similar in patients and controls. Chronic tobacco abuse results in 11beta-HSD1 enzyme induction. A reduction of 11beta-HSD1 expression in tumour tissues could be a consequence of malignantly transformed cells. It remains unclear if the lower 11beta-HSD1 expression gives rise to an increased rate of additional mutations.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/11-beta-Hydroxysteroid...,
http://linkedlifedata.com/resource/pubmed/chemical/Cytochrome P-450 CYP2D6,
http://linkedlifedata.com/resource/pubmed/chemical/HSD11B1 protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/Hydroxysteroid Dehydrogenases,
http://linkedlifedata.com/resource/pubmed/chemical/RNA, Messenger
|
pubmed:status |
MEDLINE
|
pubmed:month |
Dec
|
pubmed:issn |
0307-7772
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
27
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
453-7
|
pubmed:dateRevised |
2005-5-2
|
pubmed:meshHeading |
pubmed-meshheading:12472511-11-beta-Hydroxysteroid Dehydrogenase Type 1,
pubmed-meshheading:12472511-Carcinoma, Squamous Cell,
pubmed-meshheading:12472511-Cytochrome P-450 CYP2D6,
pubmed-meshheading:12472511-Humans,
pubmed-meshheading:12472511-Hydroxysteroid Dehydrogenases,
pubmed-meshheading:12472511-Oropharyngeal Neoplasms,
pubmed-meshheading:12472511-Pharynx,
pubmed-meshheading:12472511-Polymorphism, Restriction Fragment Length,
pubmed-meshheading:12472511-RNA, Messenger,
pubmed-meshheading:12472511-Smoking
|
pubmed:year |
2002
|
pubmed:articleTitle |
11Beta-hydroxysteroid dehydrogenase 1 expression in squamous cell carcinomas of the head and neck.
|
pubmed:affiliation |
Department of Otorhinolaryngology, University of Ulm, Germany. silke.gronau@medizin.uni-ulm.de
|
pubmed:publicationType |
Journal Article
|